http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34295461

Outgoing Links

Predicate Object
contentType Posted Content
publicationName medRxiv : the preprint server for health sciences
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c723879df57790a6c68f1f180b942f5e
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6f366f840028c21046655ef34679e498
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d81976a9d6b3aca2433feea888a4f3aa
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_30909f0d09b911b72e9d9489f51cb8ab
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8700113cc8e17ef0e69b9f035fdd622c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a91e0a837ec879e678cab156546e70e6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cfe61057b61d7ff02a235add700f6f43
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b692ee7e2b11520f86fd50e30d826730
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_22efe6d5814a784a72cff4e790b72abf
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8cfa3ebed1b9fae285870f774683b2f7
bibliographicCitation Wang L, Berger NA, Davis PB, Kaelber DC, Volkow ND, Xu R. COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022. medRxiv. 2022 Jun 22;(). PMID: 35794889; PMCID: PMC9258292.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2790c5d7fe7c5cdc0ce9695a1d939f01
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fc00dd8aa595f622d45806af0a5f8ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ffd48f468a989911217a88d106957af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_655a79b114d7a0399b52dfd094fb0554
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3127-4795
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c9b76f52bd452984c537e1086256ca9
date 2022-06-22^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/35794889
https://doi.org/10.1101/2022.06.21.22276724
https://pubmed.ncbi.nlm.nih.gov/PMC9258292
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145996610
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167

Showing number of triples: 1 to 33 of 33.